Document Detail


Long-term results of amitriptyline treatment for interstitial cystitis.
MedLine Citation:
PMID:  20094958     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: We have conducted a prospective open-label study to examine the safety and efficacy of the long-term administration of the tricyclic antidepressant amitriptyline in patients with interstitial cystitis (IC). METHODS: Patients were stratified into 2 groups: an NIDDK group including patients fulfilling the NIDDK criteria for IC and a non-NIDDK group encompassing patients who presented the characteristic IC symptoms but met at least one of the NIDDK exclusion criteria. Amitriptyline was taken strictly at bedtime following an established self-titration protocol without a limitation of the maximum daily dosage. Patients reporting improvement in a global response assessment questionnaire were defined as treatment responders. Further efficacy measures included changes of pain and urgency, functional bladder capacity and frequency. Changes in the O'Leary-Sant IC index and rating of overall satisfaction with the therapeutic outcome are reported as well. RESULTS: The mean follow-up of the study was 19.0 +/- 12.5 months. The response rate was 64% (60 patients). Overall mean dosage was 55 mg (range: 12.5-150 mg). Side effects occurred in 79 patients (84%) (dry mouth: 79%, weight gain: 59%). Patient overall satisfaction with the therapeutic result was either excellent or good in 43 patients (46%). The drop-out rate was 31% (29 patients) after a mean treatment period of 6 weeks at a mean dosage of 70 mg. Non-response to treatment was the primary reason for drop-out in all cases, side effects contributed to drop-out in 25 patients (86%). The various IC symptoms improved statistically significant compared with baseline. CONCLUSIONS: Long-term administration of amitriptyline is a feasible, safe and effective treatment for IC provided that the drug is used judiciously to minimise adverse effects. The therapeutic response to amitriptyline was uniformly observed in patients fulfilling the NIDDK criteria and in those patients with the pure clinical diagnosis of IC.
Authors:
L Hertle; A van Ophoven
Related Documents :
11755558 - Is the formation of a bladder flap at cesarean necessary? a randomized trial.
23014668 - Interpretation of endpoints in a network meta-analysis of new oral anticoagulants follo...
9720538 - Simultaneous augmentation cystoplasty and artificial urinary sphincter placement: infec...
8646238 - Summary of 10 years' experience with an ileal low-pressure bladder substitute combined ...
14763888 - Long-term efficacy of 2 year who multiple drug therapy (mdt) in multibacillary (mb) lep...
1884958 - Clinical treatment of gastroduodenal bleeding.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2010-01-21
Journal Detail:
Title:  Aktuelle Urologie     Volume:  41 Suppl 1     ISSN:  1438-8820     ISO Abbreviation:  Aktuelle Urol     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-22     Completed Date:  2010-05-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421406     Medline TA:  Aktuelle Urol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  S61-5     Citation Subset:  IM    
Affiliation:
Department of Urology, Universit?tsklinikum M?nster, University of M?nster, Germany. urologie@uni-muenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amitriptyline / administration & dosage*,  adverse effects
Antidepressive Agents, Tricyclic / administration & dosage*,  adverse effects
Antineoplastic Combined Chemotherapy Protocols / adverse effects,  therapeutic use
Cystitis, Interstitial / drug therapy*
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Long-Term Care
Male
Middle Aged
Prospective Studies
Randomized Controlled Trials as Topic
Treatment Outcome
Urodynamics / drug effects
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Tricyclic; 50-48-6/Amitriptyline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Progress in the Management of Advanced Renal Cell Carcinoma (RCC).
Next Document:  Descending Nerve-Sparing Radical Prostatectomy - Results and Consequences.